These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12396737)

  • 1. Comparative assessment of in vitro release kinetics of calcitonin polypeptide from biodegradable microspheres.
    Prabhu S; Sullivan JL; Betageri GV
    Drug Deliv; 2002; 9(3):195-8. PubMed ID: 12396737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
    Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
    J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
    Kim HK; Park TG
    J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential approach for decreasing the burst effect of protein from PLGA microspheres.
    Fu K; Harrell R; Zinski K; Um C; Jaklenec A; Frazier J; Lotan N; Burke P; Klibanov AM; Langer R
    J Pharm Sci; 2003 Aug; 92(8):1582-91. PubMed ID: 12884245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.
    Lam XM; Duenas ET; Cleland JL
    J Pharm Sci; 2001 Sep; 90(9):1356-65. PubMed ID: 11745788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of osmotic pressure in the solvent extraction phase on BSA release profile from PLGA microspheres.
    Jiang G; Thanoo BC; DeLuca PP
    Pharm Dev Technol; 2002 Nov; 7(4):391-9. PubMed ID: 12503521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
    Chowdhury DK; Mitra AK
    Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
    Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
    J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double walled POE/PLGA microspheres: encapsulation of water-soluble and water-insoluble proteins and their release properties.
    Shi M; Yang YY; Chaw CS; Goh SH; Moochhala SM; Ng S; Heller J
    J Control Release; 2003 Apr; 89(2):167-77. PubMed ID: 12711441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW; Song SH; Choi YW
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study on a slow-release complex with rifampicin-polylactic-co-glycolic acid-calcium 
phosphate cement].
    Wu J; Ding Z; Lei Q; Li M; Liang Y; Lu T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):946-54. PubMed ID: 27640793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.
    Schwach G; Oudry N; Delhomme S; Lück M; Lindner H; Gurny R
    Eur J Pharm Biopharm; 2003 Nov; 56(3):327-36. PubMed ID: 14602174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of biodegradable microspheres of testosterone with poly(D,L-lactide-co-glycolide) and test of drug release in vitro.
    Shen ZR; Zhu JH; Ma Z; Wang F; Wang ZY
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):57-64. PubMed ID: 10676577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres.
    Aubert-Pouëssel A; Bibby DC; Venier-Julienne MC; Hindré F; Benoît JP
    Pharm Res; 2002 Jul; 19(7):1046-51. PubMed ID: 12180538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.
    Vaishya RD; Mandal A; Patel S; Mitra AK
    Int J Pharm; 2015 Dec; 496(2):676-88. PubMed ID: 26561725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro.
    Seong H; An TK; Khang G; Choi SU; Lee CO; Lee HB
    Int J Pharm; 2003 Jan; 251(1-2):1-12. PubMed ID: 12527170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.
    Alcalá-Alcalá S; Urbán-Morlán Z; Aguilar-Rosas I; Quintanar-Guerrero D
    Int J Nanomedicine; 2013; 8():2141-51. PubMed ID: 23788833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L; V G S; Vavia P
    Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.